Wealth Manager - the site for professional investment managers

Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

Brewin nets close to £1m from N+1 Singer stake disposal

Brewin Dolphin has netted £0.9 million after selling its remaining stake in broker N+1 Singer.

The sale follows the merger of brokers N+1 Brewin and Singer Capital Markets last year, a move that sought to capitalise on demand from mid-caps in the UK and Europe for advisory services. N+1 Brewin was formed after the acquisition of Brewin's corporate advisory and broking businesses by the N+1 Group in 2011.

The news comes as Brewin Dolphin announced in its group preliminary results that its strategy to improve profitability and make the business more efficient had weighed on pre-tax profit, with redundancy costs amounting to £4.8 million over the year.

On a more positive note, the national wealth manager said it was starting to reap the rewards of moving to a unified pricing structure with a 25% fee rise over the year.

Total income rose 5% over the 12 months to the end of September to £283.7 million, while a 17% rise in discretionary assets powered a £3.1 billion jump in assets to £28.2 billion.  

Brewin posted a 22% rise in adjusted pre-tax profit to £52.3 million over the period. These figures were adjusted to exclude redundancy costs, additional FSCS levy, onerous contracts provision, amortisation of client relationships and disposal of available-for-sale investments.

When these factors are accounted for, pre-tax profit stood at £28.6 million, representing a 4% decline on the year. Brewin said this was down to restructuring costs and 'material provisions for onerous contracts'.

The share price was trading at 282.9 pence at 10:16, up 2.56% on the day.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Biotech Growth: we will ride out this storm

Biotech Growth: we will ride out this storm

Geoffrey Hsu of Biotech Growth Trust says the sell-off in biotechnology stocks represents a buying opportunity for long-term investors.

Play Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

In our first Sector Spotlight of the year we explore UK equities on the back of the extreme market turbulence in 2016.

Play Picton: the UK property hotspots for rental income

Picton: the UK property hotspots for rental income

Picton Property Income CEO Michael Morris reveals how he is planning to ride the ‘ripple effect’ as UK economic growth spills out from the capital across the country.

Your Business: Cover Star Club

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

In a buyers’ market for off-the-peg discretionary management, self-funded start-ups begin at an inherent disadvantage

Wealth Manager on Twitter